In the midst of escalating geopolitical competition with China, the United States must recognize the vital importance of protecting and strengthening its clinical trial infrastructure as a cornerstone of national security. As the landscape of global strategic leadership evolves, the ability to drive biotech innovation and swiftly develop cutting-edge therapeutics has become a defining factor […]
Category: regulatory affairs
Senores Pharma Arm Facility Receives 3 Observations from USFDA: A Closer Look at Senores Pharmaceuticals Limited
Senores Pharmaceuticals Limited, a global research-driven pharmaceutical company, is dedicated to developing and manufacturing a diverse range of pharmaceutical products primarily for the US, Canada, and other regulated and emerging markets. With a robust portfolio of 61 ANDA and 22 CMO/CDMO commercial products approved for distribution in the USA, Senores focuses on complex generics certified […]
The Evolving Landscape of Compliance Services in the Security Industry: Insights from the 2025 State of Continuous Compliance Report
In the rapidly evolving landscape of compliance services within the security industry, the findings from the 2025 State of Continuous Compliance Report shed light on the challenges and opportunities facing security providers. With 87% of providers now offering compliance services, the market is crowded, leading to difficulties in differentiation and demonstrating value. While the demand […]
Akums Drugs and Pharma Achieves ANVISA GMP Certification for Sterile Manufacturing Plant
Akums Drugs & Pharmaceuticals Ltd., India’s leading contract manufacturing pharmaceutical company, has proudly announced the attainment of the prestigious Good Manufacturing Practice (GMP) Certificate from ANVISA, the Brazilian Health Regulatory Agency. This achievement marks a significant advancement for Akums in the Brazilian pharmaceutical market, particularly in the field of injectables. ANVISA is renowned globally for […]
Mastering Post-Market Surveillance for Medical Devices and IVDs: A Comprehensive Training Course
In the ever-evolving landscape of medical device regulations, understanding the intricacies of post-market surveillance is paramount. The ‘Post-Market Surveillance – Practical Application for Medical Devices and IVDs Training Course’ is designed to provide participants with a comprehensive understanding of the regulatory requirements and practical application of post-market surveillance. Delving into the responsibilities of manufacturers, notified […]
Labor Unions Divided on CCCA Amendment to GENIUS Act
As the biotech industry continues to evolve, legislative changes often incite controversy among stakeholders. The recent fracas over the Durbin Marshall amendment to the GENIUS Act is a prime example of this, evoking a fierce tug-of-war between labor unions concerning the future regulatory landscape for stablecoins and credit card competition. The Teamsters Union and other […]
Federal Circuit Ruling on Clinical Trials in Jazz v. Avadel
In a recent landmark decision, the Federal Circuit overturned an injunction in the high-profile case of Jazz Pharmaceuticals v. Avadel. The ruling reframed the interpretation of §271(e)(2) within the storied Hatch-Waxman Act, suggesting it may only apply when seeking approval for a drug claimed in an Orange Book patent, a critical reference for FDA approved […]
Addressing High Drug Costs Through Patent Reform
High drug prices have become a significant issue in the United States, a symptom of a patent system that often serves entrenched interests rather than promoting innovation and improving social welfare. The problem is particularly acute in the pharmaceutical sector, where patent strategies, like those employed by AbbVie with Humira, hinder competition and maintain market […]
Effective Strategies for Regulatory Compliance in Biotech
Stay ahead of FDA warning letters with expert tips and insights on regulatory compliance in biotech. Learn from industry leaders, regulatory affairs specialists, and quality assurance experts who navigate FDA requirements daily. Gain valuable knowledge through real-world examples and practical advice to strengthen your compliance approach and safeguard your operations in the dynamic biotech industry. […]
